0001181431-13-015380.txt : 20130307
0001181431-13-015380.hdr.sgml : 20130307
20130307165058
ACCESSION NUMBER: 0001181431-13-015380
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130305
FILED AS OF DATE: 20130307
DATE AS OF CHANGE: 20130307
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Veitch David
CENTRAL INDEX KEY: 0001539762
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15313
FILM NUMBER: 13674009
MAIL ADDRESS:
STREET 1: ONE TOWER CENTER BLVD
CITY: EAST BRUNSWICK, NJ
STATE: NJ
ZIP: 08816
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000722104
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 133033811
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE TOWER CENTER
CITY: EAST BRUNSWICK
STATE: NJ
ZIP: 08816
BUSINESS PHONE: 7324189300
MAIL ADDRESS:
STREET 1: ONE TOWER CENTER
CITY: EAST BRUNSWICK
STATE: NJ
ZIP: 08816
FORMER COMPANY:
FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP
DATE OF NAME CHANGE: 19920703
4
1
rrd373196.xml
VEITCH FORM 4
X0306
4
2013-03-05
0
0000722104
SAVIENT PHARMACEUTICALS INC
SVNT
0001539762
Veitch David
MESPIL BUSINESS CENTRE
MESPIL HOUSE, SUSSEX ROAD
DUBLIN 4
L2
IRELAND
0
1
0
0
President
Savient Pharma Ireland Limited
Option to Purchase Common Stock
0.94
2013-03-05
4
A
0
110000
0
A
2023-03-05
Common Stock
110000
110000
D
Option to Purchase Common Stock
0.94
2013-03-05
4
A
0
162500
0
A
2022-01-16
Common Stock
162500
162500
D
These options will vest in proportional 25% increments on each of the first four anniversaries of the grant date, March 5, 2013.
These options were granted pursuant to the terms of Mr. Veitch's employment and vest as follows: 25% on the first anniversary of his commencement date, January 16, 2012, and an additional 6.25% at the end of each successive three-month period following the first anniversary,
Philip K. Yachmetz as attorney-in-fact for David Veitch
2013-03-07